Acadia Healthcare Company, Inc. (ACHC) Stock Forecast
ACHC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.93 / 5 from 14 analysts
- Price target
- $33.79 average of analyst targets
- Upside to target
- +12.7% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $0.46
- 52-week range
- $11.68 – $35.61
ACHC analyst ratings
14 analystsNumber of analysts at each rating.
ACHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ACHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.46 | $0.39 | $0.55 | $0.72 | −35.5% | 12 |
| Current fiscal year (2026) | $1.55 | $1.48 | $1.59 | $2.00 | −22.4% | 13 |
| Next fiscal year (2027) | $1.85 | $1.63 | $2.27 | $1.55 | +18.9% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ACHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $877.8M | $870.5M | $889.6M | +3.1% | 12 |
| Current fiscal year (2026) | $3.43B | $3.42B | $3.44B | +3.5% | 12 |
| Next fiscal year (2027) | $3.63B | $3.58B | $3.70B | +5.8% | 12 |
ACHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ACHC revenue: reported and forecast
ACHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.48 | $0.48 | $0.47 | $0.47 | $0.46 | −3.9% | 0 up · 2 down |
| Current fiscal year (2026) | $1.52 | $1.55 | $1.55 | $1.55 | $1.55 | +2.4% | 1 up · 1 down |
| Next fiscal year (2027) | $1.75 | $1.82 | $1.82 | $1.85 | $1.85 | +5.6% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ACHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ACHC beat in 10 of 12.
What analysts expect from ACHC
14 analysts cover Acadia Healthcare; their consensus rating is buy (3.93 on a 1–5 scale, where 5 is a strong buy). The average price target is $33.79, 12.7% above the latest close of $29.98. Analysts expect earnings of $1.55 per share for 2026, −22.4% from a year earlier. For 2027 the average estimate is $1.85 per share on revenue of $3.6 billion. Acadia Healthcare beat the EPS estimate in 10 of the last 12 quarters.
Related: ACHC income statement, ACHC key metrics, ACHC chart. See the ACHC stock overview for the latest quote and news.
ACHC forecast FAQ
What is Acadia Healthcare's price target?
The average analyst price target for Acadia Healthcare is $33.79, 12.7% above the latest close of $29.98.
Is Acadia Healthcare a buy, hold or sell?
Of 14 analysts covering Acadia Healthcare, 6 rate it a strong buy, 2 a buy, 5 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Acadia Healthcare's EPS forecast?
Analysts forecast $1.55 per share for 2026 (range $1.48 to $1.59); for 2027 the estimate is $1.85.
What is Acadia Healthcare's revenue forecast?
The average revenue estimate for 2026 is $3.4 billion, growth of 3.5%; for 2027 it is $3.6 billion.
When does Acadia Healthcare report earnings?
Acadia Healthcare is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes; the EPS estimate is $0.46.
Does Acadia Healthcare usually beat earnings estimates?
Acadia Healthcare reported EPS at or above the analyst estimate in 10 of the last 12 quarters.